Click for best price
Type 2 Diabetes Therapeutics Market Size, Share 2022
This report contains market size and forecasts of Type 2 Diabetes Therapeutics in Global, including the following market information:
Global Type 2 Diabetes Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Type 2 Diabetes Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DPP-4 Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Type 2 Diabetes Therapeutics include AstraZeneca, Novartis, Novo Nordisk, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Type 2 Diabetes Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Type 2 Diabetes Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Type 2 Diabetes Therapeutics Market Segment Percentages, by Type, 2021 (%)
DPP-4 Inhibitors
Biguanides
Insulins
SGLT-2 Inhibitors
?-Glucosidase Inhibitors
Other
Global Type 2 Diabetes Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Type 2 Diabetes Therapeutics Market Segment Percentages, by Application, 2021 (%)
Children
Middle-Aged Person
Aged
Global Type 2 Diabetes Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Type 2 Diabetes Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Type 2 Diabetes Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Type 2 Diabetes Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
| Report Attributes |
Report Details |
| Report Title |
Type 2 Diabetes Therapeutics Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Type 2 Diabetes Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Type 2 Diabetes Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Type 2 Diabetes Therapeutics Overall Market Size
2.1 Global Type 2 Diabetes Therapeutics Market Size: 2021 VS 2028
2.2 Global Type 2 Diabetes Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Type 2 Diabetes Therapeutics Players in Global Market
3.2 Top Global Type 2 Diabetes Therapeutics Companies Ranked by Revenue
3.3 Global Type 2 Diabetes Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Type 2 Diabetes Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Type 2 Diabetes Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Type 2 Diabetes Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Type 2 Diabetes Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Type 2 Diabetes Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Type 2 Diabetes Therapeutics Market Size Markets, 2021 & 2028
4.1.2 DPP-4 Inhibitors
4.1.3 Biguanides
4.1.4 Insulins
4.1.5 SGLT-2 Inhibitors
4.1.6 ?-Glucosidase Inhibitors
4.1.7 Other
4.2 By Type - Global Type 2 Diabetes Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Type 2 Diabetes Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Type 2 Diabetes Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Type 2 Diabetes Therapeutics Market Size, 2021 & 2028
5.1.2 Children
5.1.3 Middle-Aged Person
5.1.4 Aged
5.2 By Application - Global Type 2 Diabetes Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Type 2 Diabetes Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Type 2 Diabetes Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Type 2 Diabetes Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Type 2 Diabetes Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Type 2 Diabetes Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Type 2 Diabetes Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Type 2 Diabetes Therapeutics Revenue, 2017-2028
6.3.2 US Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.3.3 Canada Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.3.4 Mexico Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Type 2 Diabetes Therapeutics Revenue, 2017-2028
6.4.2 Germany Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.4.3 France Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.4.4 U.K. Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.4.5 Italy Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.4.6 Russia Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.4.8 Benelux Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Type 2 Diabetes Therapeutics Revenue, 2017-2028
6.5.2 China Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.5.3 Japan Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.5.4 South Korea Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.5.6 India Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Type 2 Diabetes Therapeutics Revenue, 2017-2028
6.6.2 Brazil Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.6.3 Argentina Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Type 2 Diabetes Therapeutics Revenue, 2017-2028
6.7.2 Turkey Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.7.3 Israel Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Type 2 Diabetes Therapeutics Market Size, 2017-2028
6.7.5 UAE Type 2 Diabetes Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Type 2 Diabetes Therapeutics Major Product Offerings
7.1.4 AstraZeneca Type 2 Diabetes Therapeutics Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Type 2 Diabetes Therapeutics Major Product Offerings
7.2.4 Novartis Type 2 Diabetes Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Novo Nordisk
7.3.1 Novo Nordisk Corporate Summary
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Type 2 Diabetes Therapeutics Major Product Offerings
7.3.4 Novo Nordisk Type 2 Diabetes Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Novo Nordisk Key News
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Corporate Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Major Product Offerings
7.4.4 Boehringer Ingelheim Type 2 Diabetes Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Boehringer Ingelheim Key News
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Corporate Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Major Product Offerings
7.5.4 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Bristol-Myers Squibb Key News
7.6 Eli Lilly
7.6.1 Eli Lilly Corporate Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Type 2 Diabetes Therapeutics Major Product Offerings
7.6.4 Eli Lilly Type 2 Diabetes Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Eli Lilly Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Type 2 Diabetes Therapeutics Major Product Offerings
7.7.4 Merck Type 2 Diabetes Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Merck Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Type 2 Diabetes Therapeutics Major Product Offerings
7.8.4 Sanofi Type 2 Diabetes Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Sanofi Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Type 2 Diabetes Therapeutics Market Opportunities & Trends in Global Market
Table 2. Type 2 Diabetes Therapeutics Market Drivers in Global Market
Table 3. Type 2 Diabetes Therapeutics Market Restraints in Global Market
Table 4. Key Players of Type 2 Diabetes Therapeutics in Global Market
Table 5. Top Type 2 Diabetes Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Type 2 Diabetes Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Type 2 Diabetes Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Type 2 Diabetes Therapeutics Product Type
Table 9. List of Global Tier 1 Type 2 Diabetes Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Type 2 Diabetes Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Type 2 Diabetes Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Type 2 Diabetes Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Type 2 Diabetes Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Type 2 Diabetes Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Type 2 Diabetes Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Type 2 Diabetes Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Type 2 Diabetes Therapeutics Product Offerings
Table 32. AstraZeneca Type 2 Diabetes Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Type 2 Diabetes Therapeutics Product Offerings
Table 35. Novartis Type 2 Diabetes Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Novo Nordisk Corporate Summary
Table 37. Novo Nordisk Type 2 Diabetes Therapeutics Product Offerings
Table 38. Novo Nordisk Type 2 Diabetes Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Boehringer Ingelheim Corporate Summary
Table 40. Boehringer Ingelheim Type 2 Diabetes Therapeutics Product Offerings
Table 41. Boehringer Ingelheim Type 2 Diabetes Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Bristol-Myers Squibb Corporate Summary
Table 43. Bristol-Myers Squibb Type 2 Diabetes Therapeutics Product Offerings
Table 44. Bristol-Myers Squibb Type 2 Diabetes Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Type 2 Diabetes Therapeutics Product Offerings
Table 47. Eli Lilly Type 2 Diabetes Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Type 2 Diabetes Therapeutics Product Offerings
Table 50. Merck Type 2 Diabetes Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Type 2 Diabetes Therapeutics Product Offerings
Table 53. Sanofi Type 2 Diabetes Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Type 2 Diabetes Therapeutics Segment by Type in 2021
Figure 2. Type 2 Diabetes Therapeutics Segment by Application in 2021
Figure 3. Global Type 2 Diabetes Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Type 2 Diabetes Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Type 2 Diabetes Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Type 2 Diabetes Therapeutics Revenue in 2021
Figure 8. By Type - Global Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Type 2 Diabetes Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Type 2 Diabetes Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Type 2 Diabetes Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Type 2 Diabetes Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novo Nordisk Type 2 Diabetes Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boehringer Ingelheim Type 2 Diabetes Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bristol-Myers Squibb Type 2 Diabetes Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly Type 2 Diabetes Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Type 2 Diabetes Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Type 2 Diabetes Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
